The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Quantitative Proteomics Profiling of Primary Lung Adenocarcinoma Tumors Reveals Functional Perturbations in Tumor Metabolism

På svenska

Author

  • Maria Pernemalm
  • Luigi De Petris
  • Rui M. Branca
  • Jenny Forshed
  • Lena Kanter
  • Jean-Charles Soria
  • Philippe Girard
  • Pierre Validire
  • Yudi Pawitan
  • Joost van den Oord
  • Vladimir Lazar
  • Sven Påhlman
  • Rolf Lewensohn
  • Janne Lehtio
Show all

Summary, in English

In this study, we have analyzed human primary lung adenocarcinoma tumors using global mass spectrometry to elucidate the biological mechanisms behind relapse post surgery. In total, we identified over 3000 proteins with high confidence. Supervised multivariate analysis was used to select 132 proteins separating the prognostic groups. Based on in-depth bioinformatics analysis, we hypothesized that the tumors with poor prognosis had a higher glycolytic activity and HIF activation. By measuring the bioenergetic cellular index of the tumors, we could detect a higher dependency of glycolysis among the tumors with poor prognosis. Further, we could also detect an up-regulation of HIF1 alpha mRNA expression in tumors with early relapse. Finally, we selected three proteins that were upregulated in the poor prognosis group (cathepsin D, ENO1, and VDAC1) to confirm that the proteins indeed originated from the tumor and not from a stromal or inflammatory component. Overall, these findings show how in-depth analysis of clinical material can lead to an increased understanding of the molecular mechanisms behind tumor progression.

Publishing year

2013

Language

English

Pages

3934-3943

Publication/Series

Journal of Proteome Research

Volume

12

Issue

9

Document type

Journal article

Publisher

The American Chemical Society (ACS)

Topic

  • Cancer and Oncology

Keywords

  • NSCLC
  • adenocarcinoma
  • relapse
  • glycolysis
  • hypoxia
  • HIF1
  • ENO1
  • VDAC1
  • CTSD
  • Warburg
  • prognosis
  • peptide isoelectric focusing

Status

Published

ISBN/ISSN/Other

  • ISSN: 1535-3893